1vfn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Trimeric calf spleen purine nucleoside phosphorylase has been complexed, with hypoxanthine via phosphorolysis of inosine in the presence of, phosphate. The resulting, "Michaelis" complex (three hypoxanthine, molecules per trimer), presumed to be formed under these conditions, crystallized in the cubic space group P2(1)3, with unit cell dimension a =, 94.11 A and one monomer in the asymmetric crystal unit; the biologically, active trimer is located on the crystallographic 3-fold axis., High-resolution X-ray diffraction data were collected using synchrotron, radiation (EMBL outstation, Hamburg, c/o DESY). The crystal structure has, been determined by molecular replacement and refined at 2.15 A resolution, to an R-value of 0.18. In the hypoxanthine binding site, a cis-peptide, bond between Asn243 and Lys244 is observed. Side-chains of GIu201 and, Asn243, as well as one integral water molecule located in the base binding, site, form hydrogen bonds with the hypoxanthine N-1 H, N-7 H and O-6. A, second water molecule links the base positions N-3 and N-9 with an, adjacent pocket, which presumably is the phosphate-binding site. This, pocket is filled completely by a cluster of six water molecules. Hence all, possible donor/acceptor-positions of hypoxanthine are saturated by, hydrogen-bonding to protein side-chains or integral water molecules., Purine nucleoside phosphorylase isolated form human tissues is a primary, target for chemotherapeutic intervention, and the more stable calf enzyme, has similar physico-chemical and kinetic properties, as well as response, to inhibitors. Hence the high-resolution structure presented here may, serve for design of inhibitors with potential pharmacological, applications.
+
Trimeric calf spleen purine nucleoside phosphorylase has been complexed with hypoxanthine via phosphorolysis of inosine in the presence of phosphate. The resulting, "Michaelis" complex (three hypoxanthine molecules per trimer), presumed to be formed under these conditions, crystallized in the cubic space group P2(1)3, with unit cell dimension a = 94.11 A and one monomer in the asymmetric crystal unit; the biologically active trimer is located on the crystallographic 3-fold axis. High-resolution X-ray diffraction data were collected using synchrotron radiation (EMBL outstation, Hamburg, c/o DESY). The crystal structure has been determined by molecular replacement and refined at 2.15 A resolution to an R-value of 0.18. In the hypoxanthine binding site, a cis-peptide bond between Asn243 and Lys244 is observed. Side-chains of GIu201 and Asn243, as well as one integral water molecule located in the base binding site, form hydrogen bonds with the hypoxanthine N-1 H, N-7 H and O-6. A second water molecule links the base positions N-3 and N-9 with an adjacent pocket, which presumably is the phosphate-binding site. This pocket is filled completely by a cluster of six water molecules. Hence all possible donor/acceptor-positions of hypoxanthine are saturated by hydrogen-bonding to protein side-chains or integral water molecules. Purine nucleoside phosphorylase isolated form human tissues is a primary target for chemotherapeutic intervention, and the more stable calf enzyme has similar physico-chemical and kinetic properties, as well as response to inhibitors. Hence the high-resolution structure presented here may serve for design of inhibitors with potential pharmacological applications.
==About this Structure==
==About this Structure==
Line 25: Line 25:
[[Category: transferase]]
[[Category: transferase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:16:58 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:34:46 2008''

Revision as of 13:34, 21 February 2008


1vfn, resolution 2.15Å

Drag the structure with the mouse to rotate

PURINE NUCLEOSIDE PHOSPHORYLASE

Overview

Trimeric calf spleen purine nucleoside phosphorylase has been complexed with hypoxanthine via phosphorolysis of inosine in the presence of phosphate. The resulting, "Michaelis" complex (three hypoxanthine molecules per trimer), presumed to be formed under these conditions, crystallized in the cubic space group P2(1)3, with unit cell dimension a = 94.11 A and one monomer in the asymmetric crystal unit; the biologically active trimer is located on the crystallographic 3-fold axis. High-resolution X-ray diffraction data were collected using synchrotron radiation (EMBL outstation, Hamburg, c/o DESY). The crystal structure has been determined by molecular replacement and refined at 2.15 A resolution to an R-value of 0.18. In the hypoxanthine binding site, a cis-peptide bond between Asn243 and Lys244 is observed. Side-chains of GIu201 and Asn243, as well as one integral water molecule located in the base binding site, form hydrogen bonds with the hypoxanthine N-1 H, N-7 H and O-6. A second water molecule links the base positions N-3 and N-9 with an adjacent pocket, which presumably is the phosphate-binding site. This pocket is filled completely by a cluster of six water molecules. Hence all possible donor/acceptor-positions of hypoxanthine are saturated by hydrogen-bonding to protein side-chains or integral water molecules. Purine nucleoside phosphorylase isolated form human tissues is a primary target for chemotherapeutic intervention, and the more stable calf enzyme has similar physico-chemical and kinetic properties, as well as response to inhibitors. Hence the high-resolution structure presented here may serve for design of inhibitors with potential pharmacological applications.

About this Structure

1VFN is a Single protein structure of sequence from Bos taurus with , and as ligands. Active as Purine-nucleoside phosphorylase, with EC number 2.4.2.1 Known structural/functional Sites: and . Full crystallographic information is available from OCA.

Reference

Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 A resolution., Koellner G, Luic M, Shugar D, Saenger W, Bzowska A, J Mol Biol. 1997 Jan 17;265(2):202-16. PMID:9020983

Page seeded by OCA on Thu Feb 21 15:34:46 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools